Immutep Limited - ADR

NASDAQ:IMMP   4:00:00 PM EDT
1.73
-0.12 (-6.49%)
5:13:12 PM EDT: $1.74 +0.01 (+0.58%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Immutep Limited - ADR Stock, NASDAQ:IMMP

Australia Square, 264 George Street, Sydney, New South Wales (NSW) 2000
Australia
Phone: +61.2.8315.7003
Number of Employees:
http://www.immutep.com

Description

Immutep Ltd. is a clinical stage biotechnology company, which engages in the development of LAG-3 related immunotherapeutic products for cancer and autoimmune diseases. Its products include eftilagimod alpha (IMP321), IMP761, leramilimab (IMP701), and GSK�781 (IMP731). The company was founded on May 21, 1987 and is headquartered in Sydney, Australia.